{"id":"W1699998114","doi":"10.1016/j.ctrv.2004.08.003","title":"Adjuvant chemotherapy with uracil–tegafur prolongs overall survival in people with primary adenocarcinoma of the lung☆☆☆☆☆☆Abstracted from: Kato H, Ichinose Y, Ohta M, et al. A randomized trial of adjuvant chemotherapy with uracil–tegafur for adenocarcinoma of the lung. N Engl J Med 2004;350:1713–21.","year":2004,"lang":"en","type":"letter","venue":"Cancer Treatment Reviews","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Medicine; Chemotherapy; Tegafur; Adenocarcinoma; Adjuvant; Internal medicine; Oncology; Randomized controlled trial; Lung; Adjuvant chemotherapy; Adenocarcinoma of the lung; Gastroenterology; Lung cancer; Surgery; Cancer; Breast cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.001541504,0.001769306,0.008689822,0.0002519877,0.0001483245,0.0000280692,0.0007992759,0.000663087,0.0001549954],"category_scores_gemma":[0.0002655457,0.0007434667,0.00144403,0.0007198685,0.001495562,0.0001407617,0.0000901759,0.001758149,0.0000016477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009998315,"about_ca_system_score_gemma":0.003076978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003566715,"about_ca_topic_score_gemma":0.001196745,"domain_scores_codex":[0.9917699,0.001552483,0.002602225,0.001554104,0.001538008,0.000983336],"domain_scores_gemma":[0.992029,0.001286308,0.003686743,0.002264841,0.000530645,0.0002025394],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6724416,0.003114156,0.1384396,0.006654451,0.01005789,0.0003514741,0.01097849,0.00004360933,0.0002414839,0.00001330098,0.1513244,0.006339507],"study_design_scores_gemma":[0.816228,0.004524421,0.07560378,0.01329435,0.009391358,0.0001643198,0.0001446342,0.00006000849,0.0009341564,0.00003391615,0.07851381,0.00110721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"commentary","genre_scores_codex":[0.4493984,0.2499412,0.0001585802,0.2577056,0.0006532148,0.0401927,0.001304646,0.00008520738,0.0005604142],"genre_scores_gemma":[0.3471862,0.1803704,0.006436401,0.4100243,0.003811414,0.03659073,0.003895754,0.001384118,0.01030064],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1523187,"threshold_uncertainty_score":0.9995053,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02217442976376168,"score_gpt":0.2962611633942216,"score_spread":0.27408673363046,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}